Neuronetics Inc (NASDAQ: STIM) on Tuesday, soared 9.77% from the previous trading day, before settling in for the closing price of $1.33. Within the past 52 weeks, STIM’s price has moved between $0.52 and $5.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 7.39% annually for the last half of the decade. The company achieved an average annual earnings per share of -20.96%. With a float of $15.66 million, this company’s outstanding shares have now reached $30.32 million.
In an organization with 203 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 74.23%, operating margin of -37.85%, and the pretax margin is -50.09%.
Neuronetics Inc (STIM) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Neuronetics Inc is 51.18%, while institutional ownership is 32.99%. The most recent insider transaction that took place on Oct 08 ’24, was worth 1,122. In this transaction EVP, CFO and Treasurer of this company sold 1,368 shares at a rate of $0.82, taking the stock ownership to the 497,408 shares. Before that another transaction happened on Oct 08 ’24, when Company’s EVP, GC, CCO and CS sold 1,541 for $0.82, making the entire transaction worth $1,264. This insider now owns 402,792 shares in total.
Neuronetics Inc (STIM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -20.96% per share during the next fiscal year.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Neuronetics Inc (STIM) is currently performing well based on its current performance indicators. A quick ratio of 2.87 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.24 million. That was inferior than the volume of 0.29 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.78%. Additionally, its Average True Range was 0.15.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 67.63%, which indicates a significant decrease from 79.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.09% in the past 14 days, which was lower than the 187.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0430, while its 200-day Moving Average is $1.9127. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $1.5400. Second resistance stands at $1.6200. The third major resistance level sits at $1.7650. If the price goes on to break the first support level at $1.3150, it is likely to go to the next support level at $1.1700. The third support level lies at $1.0900 if the price breaches the second support level.
Neuronetics Inc (NASDAQ: STIM) Key Stats
Market capitalization of the company is 46.82 million based on 30,348K outstanding shares. Right now, sales total 71,350 K and income totals -30,190 K. The company made 18,530 K in profit during its latest quarter, and -13,340 K in sales during its previous quarter.
